Chronic odontogenic osteomyelitis and facial actinomycosis of six‐month duration Open Access

Abstract

Introduction:

An uncommon association of chronic odontogenic osteomyelitis and an abscess in the right mandibular region with facial actinomycosis of 6 months duration after several short‐term therapy failures is described.

Case presentation:

The patient was a 55‐year‐old man with chronic inflammation of the right parotid area of the face. , and were isolated from specimens of the subtemporal abscess. Therapy started as clarithromycin and was followed by amoxicillin/clavulanate because of the resistance patterns of co‐infecting .

Conclusion:

In this case of facial actinomycosis, a successful therapeutic outcome involved a prolonged therapy as well as the detection of drug‐resistant co‐existing anaerobic bacteria.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.000729
2014-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/1/2/jmmcr000729.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.000729&mimeType=html&fmt=ahah

References

  1. Badre B., Essaadi M., El Arabi S. ( 2013). Cervicofacial actinomycosis: report of a case. Pan Afr Med J 14:147 [CrossRef]
    [Google Scholar]
  2. Barnard D., Davies J., Figdor D. ( 1996). Susceptibility of Actinomyces israelii to antibiotics, sodium hypochlorite and calcium hydroxide. Int Endod J 29:320–326 [CrossRef]
    [Google Scholar]
  3. Falchero L., Philt F., Berger F., Cordier J‐F. ( 1997). Actinomycose pulmonaire et musculo‐cutanee de la cuisse. Rev Mal Resp 14:141–143
    [Google Scholar]
  4. Jousimies‐Somer H., Summanen P., Citron D., Baron E.J., Wexler H.M., Finegold S.M. ( 2002). Wadsworth Anaerobic Bacteriology Manual. Belmont, CA: Star Publishing Company;
    [Google Scholar]
  5. Mosca A., Miragliotta L., Iodice M.A., Abbinante A., Miragliotta G. ( 2007). Antimicrobial profiles of Prevotella spp. and Fusobacterium nucleatum isolated from periodontal infections in a selected area of southern Italy. Int J Antimicrob Ag 30:521–524 [CrossRef]
    [Google Scholar]
  6. Reichenbach J., Lopatin U., Mahlaoui N., Beovic B., Siler U., Zbinden R., Seger R.A., Galmiche L., Brousse N. other authors( 2009). Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. Clin Infect Dis 49:1703–1710 [CrossRef]
    [Google Scholar]
  7. Wong V.K., Turmezei T.D., Weston V.C. ( 2011). Actinomycosis. BMJ 343:d6099 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.000729
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.000729
Loading

Data & Media loading...

Most cited Most Cited RSS feed